首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1643896

全球输液帮浦市场 - 2025-2033

Global Infusion Pumps Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 236 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球输液帮浦市场规模达164亿美元，预计2033年将达265亿美元，2025-2033年预测期间复合年增长率为4.2%。

输液帮浦是一种医疗设备，它以受控的方式向患者输送液体。基本上有许多不同类型的输液帮浦用于多种不同的目的和环境。输液帮浦可以具有非常广泛的输送设置，从大容量到低至微量输送，并且通常用于 TPN 应用和各种类型的 IV 药物 - 胰岛素和激素、化疗药物、抗生素、镇痛药等一些输液泵可在床边使用；其他设计为便携式输液泵，以提高便携性或耐磨性。

市场动态：

驱动程式和限制

科技进步的快速成长

目前，快速发展的技术进步正在全球输液帮浦市场的变革中发挥重要作用。具有无线连接的智慧输液帮浦和药物库等进步和创新为药物传递的可靠性和安全性做出了巨大贡献。这些解决方案还整合了即时监控、错误减少系统和远端程式设计等高科技功能，正在解决重症监护病房等高风险环境中病患照护的关键问题。

例如，2024年1月，全球首次开发出具有安全检测给药技术的输液帮浦。由资深研究员 Dong-kyu Lee 领导的韩国机械与材料研究所开发了客製化感测器模组，用于测量镇痛药物输注帮浦的低流量和气泡的存在。该安全泵系统正在由韩国着名的药物注射器製造商 Unimedics 开发并用于大量生产。该技术旨在防止因过量服用镇痛药物而引发的医疗事故。

产品召回

全球输液帮浦的市场成长受到产品召回的阻碍。事实上，大多数召回都是由製造缺陷、软体故障或导致患者不良暴露的安全问题引发的。这会导致品牌声誉受损，并可能导致市场成长短暂停滞。召回引发了监管机构更严格的审查，并花费数十亿美元重新设计成合规产品，这直接影响製造商的获利能力。

例如，2024 年 10 月，Zyno Medical 召回了部分 Z800 输液泵，因为管线内空气软体演算法有缺陷，可能会导致 1 mL 气泡进入患者体内。该产品可能会导致严重的不良健康后果，包括血管空气栓塞、快速心律不整、心肌梗塞、中风、癫痫发作和死亡。据报道有两人受伤。

同样，2024 年 4 月，InfuTronix, LLC 因电池故障、上游堵塞、系统错误、药品洩漏、流速高或低或外壳损坏等潜在故障模式而召回 Nimbus 输液泵系统，自 2024 年 6 月 20 日起生效。

Baxter International Inc
B. Braun Melsungen AG
Fresenius Kabi AG
ICU Medical, Inc
Terumo Corporation
Micrel Medical Devices SA
Moog Inc
Mindray Medical International Ltd
BD (Becton, Dickinson and Company)
Similar data will be provided for each market player.
科鲁医疗系统
- 管道产品说明
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估算与预测
Tandem 糖尿病护理公司
伊坦医疗
Q-Core医疗有限公司
将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录

Product Code: MD2889

The global infusion pumps market reached US$ 16.4 billion in 2024 and is expected to reach US$ 26.5 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Infusion pumps are the medical devices that's delivers a patient to flow fluids externally and in a controlled format. There are basically many different types of infusion pumps which serve several different purposes and environments. An infusion pump can have a very wide range of delivery settings from large volume down to as low as micro delivery, and often are used in both TPN applications and various types of I.V. medications - insulin and hormones, chemotherapeutic agents, antibiotics, analgesics, etc. Some infusion pumps present themselves for use at the bedside; others are designed as ambulatory infusion pumps for portability or wearability.

Market Dynamics: Drivers & Restraints

Rapid Increase of Technological Advancements

At present, fast-growing technological advancement is taking an essential part in transforming the infusion pumps market worldwide. The advancements and innovations such as smart infusion pumps with wireless connections and drug libraries have contributed a lot toward drug delivery in terms of reliability and safety. Also integrated with high-tech features such as real-time monitoring, error reduction systems, and remote programming, these solutions are addressing critical issues about patient care in high-risk settings such as intensive care units.

For instance, in January 2024, a drug infusion pump with a technology for safely detecting medication administration has been developed for the first time globally. The Korea Institute of Machinery and Materials, led by Senior Researcher Dong-kyu Lee, developed customized sensor modules to measure the low flow rate of analgesic drug infusion pumps and the presence of bubbles. The safe pump system is being developed for mass production by Unimedics, a renowned manufacturer of medication injectors in Korea. This technology aims to prevent medical accidents caused by excessive analgesic drug administration.

Product Recalls

The market growth of global infusion pumps are hindered by product recalls. In fact, most recalls are triggered by manufacturing faults, software malfunctioning, or safety issues that lead to adverse patient exposure. This results into tarnishing brand names and is capable of causing a very transient stall in market growth. Recalls provoke greater scrutiny from regulators and cost Billions of dollars to be re-engineered into compliant products which directly affect the profitability of manufacturers.

For instance, in October 2024, Zyno Medical is recalled select Z800 infusion pumps due to a defect in the air-in-line software algorithm, potentially allowing a 1 mL air bubble to pass to a patient. The product may cause serious adverse health consequences, including vascular air embolism, tachyarrhythmia, myocardial infarction, stroke, seizure, and death. There have been two reported injuries.

Similarly, in April 2024, InfuTronix, LLC is recalled Nimbus infusion pump systems due to potential failure modes such as battery failure, upstream blockage, system errors, drug product leakage, high or low flow rate, or damaged housing, effective June 20, 2024.

Segment Analysis

The global infusion pumps market is segmented based on product type, technology, application, end user and region.

Product Type:

Syringe infusion pumps segment is expected to dominate the Infusion Pumps market share

The syringe infusion pumps segment holds a major portion of the infusion pumps market share and is expected to continue to hold a significant portion of the infusion pumps market share during the forecast period.

Syringe infusion pumps are a vital component of the global infusion pumps market, providing precise and controlled delivery of small volumes of fluids and medications. They are particularly useful in critical care settings like neonatal and pediatric care, where accuracy is crucial due to patients' small size and sensitivity to dosage errors. They are also crucial for administering high-potency drugs like chemotherapy agents, anesthetics, and pain management medications. Their compact design and ability to deliver medications at low flow rates make them ideal for hospital and ambulatory care. Advancements in syringe pump technology, such as dose error reduction systems and wireless connectivity, have enhanced their efficiency and safety.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

End User:-

Hospitals segment is the fastest-growing segment in Infusion Pumps market share

The hospitals segment is the fastest-growing segment in the infusion pumps market share and is expected to hold the market share over the forecast period.

Hospitals are the largest end-users of infusion pumps globally, providing precise and controlled dosages of fluids, medications, and nutrients to patients across various departments. The increasing incidence of chronic diseases, surgical procedures, and critical care requirements has increased demand for infusion pumps.

For instance, in April 2024, Mackenzie Health has introduced BD Alaris EMR Interoperability, a two-way information flow technology that enables two-way communication between an IV medication pump and a patient's electronic medical record. This eliminates the need for healthcare professionals to manually program pumps and send infusion safety information back to Epic EMR, thereby reducing administration errors and providing accurate infusion records.

Moreover, in April 2023, Nathan Littauer Hospital & Nursing Home has opted for B Braun Medical Inc.'s Infusomat Space 2nd Generation Large Volume Pumps due to their efficiency and accuracy, ensuring safer patient care for the hospital's patients.

Geographical Analysis

North America is expected to hold a significant position in the Infusion Pumps market share

North America holds a substantial position in the infusion pumps market and is expected to hold most of the market share due to its advanced healthcare infrastructure, FDA approvals, high healthcare expenditure, and early adoption of innovative medical technologies. The region's high prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders drives demand for infusion pumps. Major market players like Medtronic, Baxter, and B. Braun ensure continuous innovation and availability of cutting-edge products. The strong regulatory framework and emphasis on patient safety drive the adoption of smart infusion pumps with integrated error-reduction systems.

For instance, in May 2024, Moog Inc has secured 510(k) clearance from the United States Food and Drug Administration (FDA) for the CURLIN 8000 Ambulatory Infusion System in the Industrial segment. This high-end infusion platform has been designed specifically for use in home infusion facilities.

Moreover, in July 2023, Becton, Dickinson and Company, or BD, is a global leader in medical technology that announced that the BD Alaris update, the latest version of the BD Alaris Infusion System, has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) to remediate and then return to full commercial operations for the most comprehensive use-infusion system in the United States.

Europe is growing at the fastest pace in the Infusion Pumps market

Europe holds the fastest pace in the infusion pumps market and is expected to hold most of the market share due to aging population and chronic diseases. Countries like Germany, France, and the UK lead the market due to their advanced healthcare systems. The focus on personalized medicine and homecare has increased demand for portable infusion pumps. The European Union's focus on reducing hospital stays and promoting outpatient care has fueled the adoption of infusion technology in ambulatory settings. Government funding, collaborations, and competitive pricing from local and international manufacturers drive market growth.

For instance, in May 2023, Fresenius Kabi announced that it has joined Premier, Inc. in a Breakthrough Technology group purchasing agreement. Under the agreement, which comes into effect May 1, 2023, Premier members may opt to take advantage of special pricing and terms negotiated in advance by Premier for the Ivenix Infusion System from Fresenius Kabi.

Competitive Landscape

The major global players in the infusion pumps market include Medtronic plc, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical, Inc, Terumo Corporation, Micrel Medical Devices SA, Moog Inc, Mindray Medical International, Ltd, BD (Becton, Dickinson and Company) and among others.

Key Developments

In June 2023, B. Braun Medical Inc. has launched DoseTrac Enterprise Infusion Management Software, a next-generation infusion management software. The software offers real-time views and retrospective reporting features to help organizations understand their infusion pump fleet and associated data. It can connect up to 40,000 pumps at an unlimited number of facilities with just one application.
In February 2023, Mindray has introduced its BeneFusion i Series and u Series infusion systems, offering high precision, adaptive customization, and simplicity for medication safety in various clinical settings, available in select countries and regions.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global infusion pumps market report delivers a detailed analysis with 68+ key tables, more than 72 visually impactful figures, and 236 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rapid Increase of Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Product Recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Syringe Infusion Pumps*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Volumetric Infusion Pumps
6.4. Ambulatory Infusion Pumps
6.5. Insulin Infusion Pumps
6.6. Patient-Controlled Analgesia (PCA) Pumps
6.7. Elastomeric Pumps
6.8. Implantable Infusion Pumps
6.9. Enteral Infusion Pumps

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Traditional Pumps*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Smart Pumps
7.4. Wearable Pumps

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Oncology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diabetes Management
8.4. Gastroenterology
8.5. Pediatrics/Neonatology
8.6. Analgesia/Pain Management
8.7. Cardiology
8.8. Critical Care/ICU
8.9. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers (ASCs)
9.4. Homecare Settings
9.5. Specialty Clinics

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Baxter International Inc
12.3. B. Braun Melsungen AG
12.4. Fresenius Kabi AG
12.5. ICU Medical, Inc
12.6. Terumo Corporation
12.7. Micrel Medical Devices SA
12.8. Moog Inc
12.9. Mindray Medical International Ltd
12.10. BD (Becton, Dickinson and Company)
Similar data will be provided for each market player.

Emerging Market Players

12.11. KORU Medical Systems*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. Tandem Diabetes Care, Inc
12.13. Eitan Medical
12.14. Q-Core Medical Ltd
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE